JPWO2023171719A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023171719A5
JPWO2023171719A5 JP2024506376A JP2024506376A JPWO2023171719A5 JP WO2023171719 A5 JPWO2023171719 A5 JP WO2023171719A5 JP 2024506376 A JP2024506376 A JP 2024506376A JP 2024506376 A JP2024506376 A JP 2024506376A JP WO2023171719 A5 JPWO2023171719 A5 JP WO2023171719A5
Authority
JP
Japan
Prior art keywords
vector
amino acid
acid sequence
protein
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506376A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023171719A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/008880 external-priority patent/WO2023171719A1/ja
Publication of JPWO2023171719A1 publication Critical patent/JPWO2023171719A1/ja
Publication of JPWO2023171719A5 publication Critical patent/JPWO2023171719A5/ja
Pending legal-status Critical Current

Links

JP2024506376A 2022-03-08 2023-03-08 Pending JPWO2023171719A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022035659 2022-03-08
PCT/JP2023/008880 WO2023171719A1 (ja) 2022-03-08 2023-03-08 活性化プロテインｃ配列

Publications (2)

Publication Number Publication Date
JPWO2023171719A1 JPWO2023171719A1 (https=) 2023-09-14
JPWO2023171719A5 true JPWO2023171719A5 (https=) 2024-12-17

Family

ID=87935247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506376A Pending JPWO2023171719A1 (https=) 2022-03-08 2023-03-08

Country Status (3)

Country Link
US (1) US20250177571A1 (https=)
JP (1) JPWO2023171719A1 (https=)
WO (1) WO2023171719A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
JP2000501928A (ja) * 1995-11-30 2000-02-22 ザイモジェネティクス，インコーポレイティド トランスジェニック動物におけるプロテインｃの製造
EP1090130A1 (en) * 1999-04-30 2001-04-11 Eli Lilly And Company Protein c derivatives
AU2001249389A1 (en) * 2000-03-22 2001-10-03 The Children's Hospital Of Philadelphia Modified blood clotting factors and methods of use
JP6549559B2 (ja) * 2013-04-29 2019-07-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 標的細胞における活動電位の光遺伝学的調節のための装置、システム及び方法

Similar Documents

Publication Publication Date Title
CN113316639A (zh) 用于治疗庞贝氏病的治疗性腺相关病毒
FI3510049T3 (fi) Happo alfa-glukosidaasin muunnoksia ja niiden käyttöjä
KR950001992B1 (ko) 배양된 세포내에서 바쿨로바이러스 벡터를 이용한 펩타이드의 제조방법
JPWO2014061735A1 (ja) ヒトβ−ヘキソサミニダーゼＢの基質特異性を変換し、且つ、プロテアーゼ抵抗性を付与した新規高機能酵素
CN101475938A (zh) 包虫病抗原基因即egG1Y162抗原基因及其重组蛋白和应用
CN104311671A (zh) 猫长效融合干扰素及其制备方法与应用
JP2862870B2 (ja) 新規ペプチド
JPWO2023171719A5 (https=)
JP7745307B2 (ja) 連結ペプチド、連結ペプチドを含む血液凝固ｖｉｉｉ因子タンパク質又はその変異体及びその用途
TWI235160B (en) Anti-viral therapy
KR20040097249A (ko) 중공 나노입자를 형성하는 단백질에 질환 치료용 세포도입 물질을 융합시킨 약제
JP2002508181A5 (https=)
CN105085659B (zh) 一种重组利钠肽及其制备方法
EP1226256B1 (en) Recombinant bifunctional fusion proteins for the clearance of variable viruses
CN106636175A (zh) 细胞损伤修复蛋白在毕氏酵母中的诱导表达、纯化方法及其应用
JPH05103666A (ja) ヒト神経成長因子を発現させるための方法
CN115678912B (zh) 一种构建dgtm转基因斑马鱼作为载体表达人源dgtm蛋白的方法
JP3029272B2 (ja) 構造蛋白質遺伝子、組換えベクター、組換えウイルス、ポリペプチドおよびポリペプチドの製造方法
US20260035678A1 (en) Biological product, method and application thereof
JPH08510903A (ja) 蛭ヒルド・メディシナリスの組換えｘａ因子インヒビターの作製
Houard et al. Cloning, expression and purification of recombinant cotton rat interferon-gamma
US20030044982A1 (en) Method to treat hemophilia by hepatic gene transfer of factor VIII/IX with vesicle vector
JPS6345227A (ja) Ｂ型肝炎ウイルス表面抗原蛋白質
CN119161495A (zh) 呼吸道合胞病毒重构多肽及其应用
CN116726159A (zh) 一种用于呼吸道合胞病毒感染的重组腺病毒疫苗